Media / Collateral - Latham BioPharm Group

Sia/LBG’s Andrew B. Harmon, a recognized subject matter expert providing strategic insights across the biopharmaceutical industry, recently presented a forward-looking model for the viral vector market at BioProcess International Europe …

Jan 13, 2025

LBG’s Patrick Falvey Featured in the American Pharmaceutical Review for Expertise on Global Biomanufacturing Trends

We are proud to share that Patrick Falvey, Principal Consultant at Latham BioPharma Group (LBG), was featured in the American Pharmaceutical Review! In his interview, published on October 1, 2024, …

Featured Collateral

View More Collateral

Whitepaper

Challenges of Commercial-Scale Autologous CART-T Cell Manufacturing

View Whitepaper

Whitepaper

The Importance of ROI Evaluation in the Pharmaceutical/Biotechnology Industry

View Whitepaper

Whitepaper

Innovator Requirements for the Selection of a CAR-T CDMO

View Whitepaper

Whitepaper

Outsourcing Biosimilar Development, BioProcess International’s March 2017 Featured Report

View Whitepaper

Featured Case Studies

View More Case Studies

Case Study

Program Support for Development of Novel Vaccine Platform

View Case Study

Case Study

Program Support for Completion of Two Phase 2 Clinical Studies and Development of Vaccine Platform

View Case Study